(株)リボミックの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4591/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/04/03 | 日証協 | 448,200株 | +1.66% | 76,400株 | +54.03% | 351,118株 | +2.87% | 33,586株 | +1.78% |
2015/03/20 | 日証協 | 402,600株 | +2.55% | 96,800株 | +1087.44% | 321,108株 | +1.94% | 31,110株 | +174.94% |
2015/03/13 | 日証協 | 392,600株 | -0.77% | 8,152株 | -88.89% | 314,993株 | +1.71% | 11,315株 | +5.75% |
2015/03/06 | 日証協 | 395,648株 | -9.43% | 73,348株 | +48.18% | 309,693株 | -4.68% | 10,700株 | -52.7% |
2015/02/27 | 日証協 | 436,848株 | +6.61% | 49,500株 | -23.43% | 324,893株 | +4.58% | 22,620株 | +86.33% |
2015/02/20 | 日証協 | 409,748株 | +0.69% | 64,648株 | -6.03% | 310,663株 | +1.38% | 12,140株 | -65.99% |
2015/02/13 | 日証協 | 406,948株 | +5.96% | 68,800株 | +31.05% | 306,433株 | +5.48% | 35,700株 | -6.08% |
2015/02/06 | 日証協 | 384,048株 | +4.97% | 52,500株 | -34.33% | 290,523株 | +4.2% | 38,010株 | +32.39% |
2015/01/30 | 日証協 | 365,848株 | -1.23% | 79,948株 | +1408.45% | 278,823株 | +2.69% | 28,710株 | +189.94% |
2015/01/23 | 日証協 | 370,400株 | -1.88% | 5,300株 | -93.6% | 271,511株 | -0.69% | 9,902株 | -13.9% |
2015/01/16 | 日証協 | 377,500株 | +2.72% | 82,800株 | +64.61% | 273,411株 | +2.01% | 11,500株 | -53.06% |
2015/01/09 | 日証協 | 367,500株 | +11.91% | 50,300株 | 0% | 268,011株 | +7.76% | 24,500株 | +965.22% |
2014/12/30 | 日証協 | 328,400株 | +2.59% | 0株 | -100% | 248,711株 | +0.85% | 2,300株 | -91.73% |
2014/12/26 | 日証協 | 320,100株 | +16.53% | 40,800株 | -64.34% | 246,611株 | +14.54% | 27,800株 | -42.32% |
2014/12/19 | 日証協 | 274,700株 | +24.02% | 114,400株 | +1055.56% | 215,311株 | +10.52% | 48,200株 | +288.71% |
2014/12/12 | 日証協 | 221,500株 | -1.25% | 9,900株 | +395% | 194,811株 | -3.75% | 12,400株 | +29.17% |
2014/12/05 | 日証協 | 224,300株 | -1.23% | 2,000株 | -93.98% | 202,411株 | +5.25% | 9,600株 | -56.95% |
2014/11/28 | 日証協 | 227,100株 | +4.56% | 33,200株 | +159.38% | 192,321株 | -6.39% | 22,300株 | +34.18% |
2014/11/21 | 日証協 | 217,200株 | -33.74% | 12,800株 | -20.5% | 205,441株 | -20.63% | 16,620株 | -23.13% |
※株式分割は考慮していませんのでご注意ください。
Page Top